Imatinib for paediatric leukaemia
Imatinib for paediatric leukaemia
Andrea Biondi joins The Lancet Haematology to discuss his work on imatinib as a treatment for paediatric Philadelphia ch... Read more
15 Dec 2018
•
8mins
Predicting the risk of adenoviraemia
Predicting the risk of adenoviraemia
Prashant Hiwarkar joins The Lancet Haematology to discuss his new paper, an investigation into whether serial faecal PCR... Read more
31 Aug 2018
•
4mins
Adverse events in haematological malignancies
Adverse events in haematological malignancies
Lead author Gita Thanarajasingam joins The Lancet Haematology to discuss the new Commission on assessment and adverse ev... Read more
12 Jun 2018
•
12mins
Adverse events in haematological malignancies
Adverse events in haematological malignancies
Lead author Gita Thanarajasingam joins The Lancet Haematology to discuss the new Commission on assessment and adverse ev... Read more
12 Jun 2018
•
12mins
EPO blood doping and cycling: The Lancet Haematology: June 29, 2017
EPO blood doping and cycling: The Lancet Haematology: June 29, 2017
Jules Heuberger talks about his study on the effectiveness of EPO use by cyclists.
30 Jun 2017
•
8mins
EPO blood doping and cycling: The Lancet Haematology: June 29, 2017
EPO blood doping and cycling: The Lancet Haematology: June 29, 2017
Jules Heuberger talks about his study on the effectiveness of EPO use by cyclists.
30 Jun 2017
•
8mins
Trauma-induced coagulopathy: The Lancet Haematology: June issue
Trauma-induced coagulopathy: The Lancet Haematology: June issue
Petra Innerhofer discusses reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or f... Read more
3 Jun 2017
•
9mins
Trauma-induced coagulopathy: The Lancet Haematology: June issue
Trauma-induced coagulopathy: The Lancet Haematology: June issue
Petra Innerhofer discusses reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or f... Read more
3 Jun 2017
•
9mins
Childhood leukaemia survival (CONCORD-2): The Lancet Haematology: April 11, 2017
Childhood leukaemia survival (CONCORD-2): The Lancet Haematology: April 11, 2017
Audrey Bonaventure discusses her CONCORD-2 study, monitoring survival trends of two types of childhood leukaemia in 53 c... Read more
12 Apr 2017
•
5mins
Childhood leukaemia survival (CONCORD-2): The Lancet Haematology: April 11, 2017
Childhood leukaemia survival (CONCORD-2): The Lancet Haematology: April 11, 2017
Audrey Bonaventure discusses her CONCORD-2 study, monitoring survival trends of two types of childhood leukaemia in 53 c... Read more
12 Apr 2017
•
5mins